• to lessen the chance of major cardiovascular (heart and blood vessel) problems in adults with style 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk printed a research on scientific journal Character about a novel glucose-sensitive insulin NNC2215 which will lower the chance of hypoglycemia in animal models.[67]are scheduled to have surgi